The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field (Q34489055)

2 August 2017

title

The Use of Ebola Convalescent Plasma to Treat Ebola Virus Disease in Resource-Constrained Settings: A Perspective From the Field (English)

1 reference

2 August 2017

main subject

Ebola hemorrhagic fever

0 references

Orthoebolavirus zairense

0 references

1 reference

Peter G Smith

4

0 references

Robert Colebunders

8

object named as

Robert Colebunders

1 reference

2 August 2017

1

Johan van Griensven

1 reference

2 August 2017

3

Alexandre Delamou

1 reference

2 August 2017

Tansy Edwards

5

0 references

Lut Lynen

object named as

Lutgarde Lynen

12

0 references

Catherine Lazaygues

10

object named as

Catherine Lazaygues

1 reference

2 August 2017

7

Elhadj Ibrahima Bah

1 reference

2 August 2017

11

Nyankoye Haba

1 reference

2 August 2017

Anja De Weiggheleire

2

1 reference

2 August 2017

Philippe Vandekerckhove

6

1 reference

2 August 2017

Isola Herve

9

1 reference

2 August 2017

language of work or name

English

0 references

publication date

10 August 2015

1 reference

Clinical Infectious Diseases

2 August 2017

published in

1 reference

2 August 2017

volume

62

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

69-74

1 reference

Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Passive immunotherapy with dromedary immune serum in an experimental animal model for Middle East respiratory syndrome coronavirus infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Minipool caprylic acid fractionation of plasma using disposable equipment: a practical method to enhance immunoglobulin supply in developing countries

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Ebola virus convalescent blood products: where we are now and where we may need to go.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Clinical care of two patients with Ebola virus disease in the United States

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Randomised controlled trials for Ebola: practical and ethical issues

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Hark back: passive immunotherapy for influenza and other serious infections.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Clinical uses of intravenous immunoglobulin.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Passive antibody therapy for infectious diseases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Antibody-dependent enhancement of Ebola virus infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

The use of Lassa fever convalescent plasma in Nigeria

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Lassa fever. Effective therapy with ribavirin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

A case of Ebola virus infection

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4678103

Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995: determinants of survival

6 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV680

Ebola: a call for blood transfusion strategy in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV680

Blood as medicine: social meanings of blood and the success of Ebola trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV680

Community perception and beliefs about blood draw for clinical research in Ghana

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV680

Large-scale convalescent blood and plasma transfusion therapy for Ebola virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIV680

21 January 2018

Identifiers

DOI

10.1093/CID/CIV680

1 reference

2 August 2017

1 reference

2 August 2017

1 reference